UCP2 and neoplasm: In the later stages of tumorigenesis, UCP2 expression levels are upregulated to meet the metabolic needs of the tumor tissue, such as maintaining high ATP production, providing ROS protection, promoting therapeutic resistance, and facilitating immune evasion (Donadelli et al. 2015).